Effects of Ginkgo biloba extract on cell proliferation, cytokines and extracellular matrix of hepatic stellate cells

Liver International

Volumn 26, Issue 10, 2006, Pages 1283-1290

  Zhang, Chunqing ^a   Zhu, Yuhua ^a   Wan, Jing ^a   Xu, Hongwei ^a   Shi, Henmei ^a   Lu, Xiaoxia ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Connective tissue growth factor; Extracellular matrix; Ginkgo biloba extract; Hepatic stellate cell; Transforming growth factor I

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; GINKGO BILOBA EXTRACT; HYALURONIC ACID; LAMININ; MESSENGER RNA; PROCOLLAGEN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; EXTRACELLULAR MATRIX; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; GINKGO BILOBA; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER CIRRHOSIS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33750978411     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01378.x     Document Type: Article

References (27)

1. 4-induced liver fibrosis in rats. World J Gastroenterol 2004; 10: 1037-42.
2. Friedman S L. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004; 1: 98-105.
3. Friedman S L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-50.
4. Friedman S L. Cytokines and fibrogenesis. Semin Liver Dis 1999; 19: 129-40.
5. Czaja M J, Weiner F R, Flanders K C, et al. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol 1989; 108: 2477-82.
6. Chen M M, Lam A, Abraham J A, Schreiner G F, Joly A H. CTGF expression is induced by TGFbeta in cardiac fibroblasts and cardiac myocytes: A potential role in heart fibrosis. J Mol Cell Cardiol 2000; 32: 1805-19.
7. Beek T A. Chemical analysis of Ginkgo biloba leaves and extracts. J Chromatogr A 2002; 967: 21-55.
8. Kobuchi H, Droy-Lefaix M T, Christen Y, Packer L. Ginkgo biloba extract (EGb 761): Inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol 1997; 53: 897-903.
9. Lamant V, Mauco G, Braquet P, Chap H, Douste-Blazy L. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Biochem Pharmacol 1987; 36: 2749-52.
10. 1 mRNA and deposititon of collagen in CCl4 rats. Zhong Xi Yi Jie Gang Bing Zazhi 2004: 32-34 (Chinese).
11. Ding J, Yu J, Wang C, et al. Ginkgo biloba extract alleviates liver fibrosis induced by CCl4 in rats. Liver Int 2005; 25: 1224-32.
12. Liu S Q, Yu J P, Chen H L, Luo H S, Chen S M, Yu H G. Therapeutic effects and molecular mechanisms of Ginkgo biloba extract on liver fibrosis in rats. Am J Chin Med 2006; 34: 99-114.
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
14. Friedman S L. Liver fibrosis - from bench to bedside. J Hepatol 2003; 38 (Suppl 1): S38-53.
15. Vogel S, Piantedosi R, Frank J, et al. An immortalized rat liver stellate cell line (HSC-T6): A new cell model for the study of retinoid metabolism in vitro. J Lipid Res 2000; 41: 882-93.
16. Kim Y, Ratziu V, Choi S G, et al. Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem 1998; 273: 33750-8.
17. Okuno M, Moriwaki H, Imai S, et al. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells. Hepatology 1997; 26: 913-21.
18. Bachem M G, Meyer D, Melchior R, Sell K M, Gressner A M. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992; 89: 19-27.
19. Monteleone G, Kumberova A, Croft N M, McKenzie C, Steer H W, MacDonald T T. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J Clin Invest 2001; 108: 601-9.
20. Bissell D M. Cell-matrix interaction and hepatic fibrosis. Prog Liver Dis 1990; 9: 143-55.
21. Shek F W, Benyon R C. How can transforming growth factor beta be targeted usefully to combat liver fibrosis? Eur J Gastroenterol Hepatol 2004; 16: 123-6.
22. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst G R. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107: 404-11.
23. Rojkind M, Perez-Tamayo R. Liver fibrosis. Int Rev Connect Tissue Res 1983; 10: 333-93.
24. Ignotz R A, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337-45.
25. Broekelmann T J, Limper A H, Colby T V, McDonald J A. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991; 88: 6642-6.
26. Ogawa K, Chen F, Kuang C, Chen Y. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem J 2004; 381: 413-22.
27. Verrecchia F, Chu M L, Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/ promoter transactivation approach. J Biol Chem 2001; 276: 17058-62.